BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15987497)

  • 1. Modeling human arthritic diseases in nonhuman primates.
    Vierboom MP; Jonker M; Bontrop RE; 't Hart B
    Arthritis Res Ther; 2005; 7(4):145-54. PubMed ID: 15987497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-human primate models of experimental autoimmune encephalomyelitis: Variations on a theme.
    't Hart BA; Bauer J; Brok HP; Amor S
    J Neuroimmunol; 2005 Nov; 168(1-2):1-12. PubMed ID: 16023737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical models of arthritic disease in non-human primates.
    Vierboom MP; Jonker M; Tak PP; 't Hart BA
    Drug Discov Today; 2007 Apr; 12(7-8):327-35. PubMed ID: 17395093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis.
    Hegen M; Keith JC; Collins M; Nickerson-Nutter CL
    Ann Rheum Dis; 2008 Nov; 67(11):1505-15. PubMed ID: 18055474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of genetic studies in rodent models of autoimmune arthritis to understanding and treatment of rheumatoid arthritis.
    Gulko PS
    Genes Immun; 2007 Oct; 8(7):523-31. PubMed ID: 17703178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of non-human primates as preclinical models of human arthritic disease.
    Vierboom M; Breedveld E; Kondova I; 't Hart BA
    Expert Opin Drug Discov; 2008 Mar; 3(3):299-310. PubMed ID: 23480265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis.
    Nandakumar KS; Holmdahl R
    J Immunol Methods; 2005 Sep; 304(1-2):126-36. PubMed ID: 16125192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drug discovery strategies for rheumatoid arthritis: a niche for nonhuman primate models to address systemic complications in inflammatory arthritis.
    Vierboom M; Breedveld E; 't Hart BA
    Expert Opin Drug Discov; 2012 Apr; 7(4):315-25. PubMed ID: 22458503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictivity and sensitivity of animal models of arthritis.
    Di Paola R; Cuzzocrea S
    Autoimmun Rev; 2008 Oct; 8(1):73-5. PubMed ID: 18708167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation.
    Nandakumar KS; Bajtner E; Hill L; Böhm B; Rowley MJ; Burkhardt H; Holmdahl R
    Arthritis Rheum; 2008 Jan; 58(1):184-96. PubMed ID: 18163493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental animal models for rheumatoid arthritis.
    Choudhary N; Bhatt LK; Prabhavalkar KS
    Immunopharmacol Immunotoxicol; 2018 Jun; 40(3):193-200. PubMed ID: 29433367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of arthritis caused by systemic alteration of the immune system.
    Sakaguchi S; Sakaguchi N
    Curr Opin Immunol; 2005 Dec; 17(6):589-94. PubMed ID: 16214319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha.
    Williams RO
    Methods Mol Biol; 2007; 361():265-84. PubMed ID: 17172717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model.
    Shou J; Bull CM; Li L; Qian HR; Wei T; Luo S; Perkins D; Solenberg PJ; Tan SL; Chen XY; Roehm NW; Wolos JA; Onyia JE
    Arthritis Res Ther; 2006; 8(1):R28. PubMed ID: 16507131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpesvirus entry mediator-Ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model.
    Pierer M; Schulz A; Rossol M; Kendzia E; Kyburz D; Haentzschel H; Baerwald C; Wagner U
    J Immunol; 2009 Mar; 182(5):3139-45. PubMed ID: 19234211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
    Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease.
    Monach PA; Benoist C; Mathis D
    Adv Immunol; 2004; 82():217-48. PubMed ID: 14975258
    [No Abstract]   [Full Text] [Related]  

  • 19. The unique value of primate models in translational research. Nonhuman primate models of women's health: introduction and overview.
    Shively CA; Clarkson TB
    Am J Primatol; 2009 Sep; 71(9):715-21. PubMed ID: 19507247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
    Zhou F; He X; Iwakura Y; Horai R; Stuart JM
    Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.